journal article·2018-11-27

Stimuli-Responsive Nano-Architecture Drug-Delivery Systems to Solid Tumor Micromilieu: Past, Present, and Future Perspectives

Hossam S. El-Sawy, Ahmed M. Al-Abd, Tarek A. Ahmed, Khalid M. El-Say, Vladimir P. Torchilin

ACS Nano· Volume 12· Issue 11
Publisher page

Abstract

The microenvironment characteristics of solid tumors, renowned as barriers that harshly impeded many drug-delivery approaches, were precisely studied, investigated, categorized, divided, and subdivided into a complex diverse of barriers. These categories were further studied with a particular perspective, which makes all barriers found in solid-tumor micromilieu turn into different types of stimuli, and were considered triggers that can increase and hasten drug-release targeting efficacy. This review gathers data concerning the nature of solid-tumor micromilieu. Past research focused on the treatment of such tumors, the recent efforts employed for engineering smart nanoarchitectures with the utilization of the specified stimuli categories, the possibility of combining more than one stimuli for much-greater targeting enhancement, examples of the approved nanoarchitectures that already translated clinically as well as the obstacles faced by the use of these nanostructures, and, finally, an overview of the possible future implementations of smart-chemical engineering for the design of more-efficient drug delivery and theranostic systems and for making nanosystems with a much-higher level of specificity and penetrability features.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo 63514, Egypt

Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates

Pharmacology Department, Medical Division, National Research Centre, Giza 12622, Egypt

Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo 11651, Egypt

Department of Pharmaceutical Sciences Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, 140 The Fenway, Room 211/214, 360 Huntington Aveue, Boston, Massachusetts 02115, United States

References (100+)

Show source-provided references
1. 10.3389/fonc.2013.0019310.3389/fonc.2013.00193 ↗
2. 10.2174/138161282166615053117062110.2174/1381612821666150531170621 ↗
3. 10.1016/j.ejca.2014.04.01410.1016/j.ejca.2014.04.014 ↗
4. 10.1158/0008-5472.CAN-08-023710.1158/0008-5472.CAN-08-0237 ↗
5. 10.1016/j.jare.2014.11.00810.1016/j.jare.2014.11.008 ↗
6. 10.1038/nrc70610.1038/nrc706 ↗
7. 10.1016/j.jconrel.2015.08.05510.1016/j.jconrel.2015.08.055 ↗
8. 10.1081/PDT-12000348710.1081/PDT-120003487 ↗
9. 10.1093/sleep/2.4.45310.1093/sleep/2.4.453 ↗
10. 10.1038/sj.onc.120423510.1038/sj.onc.1204235 ↗
11. 10.1152/ajplegacy.1959.196.2.38110.1152/ajplegacy.1959.196.2.381 ↗
12. 10.1016/j.jare.2017.06.00610.1016/j.jare.2017.06.006 ↗
13. 10.1080/0735790070166250910.1080/07357900701662509 ↗
14. Maeda H. · 2002 · 21110.1007/978-1-4757-4627-3_11 ↗
15. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
16. 10.1016/j.drudis.2006.07.00510.1016/j.drudis.2006.07.005 ↗
17. 10.1186/s40169-018-0185-610.1186/s40169-018-0185-6 ↗
18. 10.1016/j.xphs.2017.06.01910.1016/j.xphs.2017.06.019 ↗
19. 10.1016/j.addr.2018.07.00710.1016/j.addr.2018.07.007 ↗
20. 10.1016/j.jconrel.2014.03.05710.1016/j.jconrel.2014.03.057 ↗
21. 10.1016/j.jconrel.2011.09.06310.1016/j.jconrel.2011.09.063 ↗
22. 10.1016/j.nantod.2012.10.01010.1016/j.nantod.2012.10.010 ↗
23. Jain R. K. · Cancer Res. · 1987 · 47 · 3039
24. 10.1038/sj.neo.790003710.1038/sj.neo.7900037 ↗
25. 10.1016/j.jconrel.2016.11.01510.1016/j.jconrel.2016.11.015 ↗
26. 10.1016/j.addr.2016.04.02510.1016/j.addr.2016.04.025 ↗
27. 10.1016/j.jconrel.2018.02.04010.1016/j.jconrel.2018.02.040 ↗
28. 10.1016/j.jconrel.2016.04.02810.1016/j.jconrel.2016.04.028 ↗
29. 10.1152/ajplung.00436.200610.1152/ajplung.00436.2006 ↗
30. 10.2147/IJN.S306110.2147/IJN.S3061 ↗
31. 10.2174/157016104338573610.2174/1570161043385736 ↗
32. 10.1126/science.95984010.1126/science.959840 ↗
33. 10.1126/science.268307510.1126/science.2683075 ↗
34. 10.1126/science.220410810.1126/science.2204108 ↗
35. Pluda J. M. · Semin. Oncol. · 1997 · 24 · 203
36. 10.1259/0007-1285-66-783-18110.1259/0007-1285-66-783-181 ↗
37. Folkman J. · N. Engl. J. Med. · 1971 · 285 · 118210.1056/NEJM197108122850711 ↗
38. 10.1016/j.jpedsurg.2006.09.04810.1016/j.jpedsurg.2006.09.048 ↗
39. 10.1038/nrc189310.1038/nrc1893 ↗
40. 10.1158/0008-5472.CAN-05-307710.1158/0008-5472.CAN-05-3077 ↗
41. 10.1093/jnci/djm13510.1093/jnci/djm135 ↗
42. 10.1016/j.ccell.2014.10.00610.1016/j.ccell.2014.10.006 ↗
43. 10.1016/j.canlet.2014.04.00110.1016/j.canlet.2014.04.001 ↗
44. 10.1200/JCO.2006.07.109210.1200/JCO.2006.07.1092 ↗
45. 10.1115/1.403499110.1115/1.4034991 ↗
46. 10.1016/j.jtbi.2012.11.03110.1016/j.jtbi.2012.11.031 ↗
47. 10.1038/nbt0897-77810.1038/nbt0897-778 ↗
48. 10.3174/ajnr.A231210.3174/ajnr.A2312 ↗
49. Thews O. · 2011 · 701 · 11510.1007/978-1-4419-7756-4_16 ↗
50. 10.1002/ijc.2381810.1002/ijc.23818 ↗
51. 10.1016/j.jconrel.2015.08.01210.1016/j.jconrel.2015.08.012 ↗
52. 10.1016/j.jconrel.2014.01.01210.1016/j.jconrel.2014.01.012 ↗
53. 10.2217/nnm.11.14110.2217/nnm.11.141 ↗
54. 10.1021/mp100438310.1021/mp1004383 ↗
55. 10.1124/jpet.107.12163210.1124/jpet.107.121632 ↗
56. 10.1016/S0092-8674(00)80108-710.1016/S0092-8674(00)80108-7 ↗
57. 10.1016/S1470-2045(00)00323-510.1016/S1470-2045(00)00323-5 ↗
58. 10.3892/ijo.2016.370910.3892/ijo.2016.3709 ↗
59. 10.1016/j.bbcan.2014.05.00210.1016/j.bbcan.2014.05.002 ↗
60. 10.1038/nrc244210.1038/nrc2442 ↗
61. 10.1038/nnano.2012.4510.1038/nnano.2012.45 ↗
62. 10.1158/0008-5472.CAN-12-435410.1158/0008-5472.CAN-12-4354 ↗
63. 10.1101/cshperspect.a00648610.1101/cshperspect.a006486 ↗
64. 10.1126/science.112595010.1126/science.1125950 ↗
65. 10.1158/0008-5472.CAN-05-259810.1158/0008-5472.CAN-05-2598 ↗
66. 10.1158/0008-5472.CAN-05-076510.1158/0008-5472.CAN-05-0765 ↗
67. Man S. · Cancer Res. · 2002 · 62 · 2731
68. 10.1158/1535-7163.MCT-07-018110.1158/1535-7163.MCT-07-0181 ↗
69. 10.1093/jnci/djv01710.1093/jnci/djv017 ↗
70. 10.1016/j.ccr.2004.10.01110.1016/j.ccr.2004.10.011 ↗
71. 10.1038/ncpcardio097910.1038/ncpcardio0979 ↗
72. 10.1101/cshperspect.a00648610.1101/cshperspect.a006486 ↗
73. 10.1126/science.108134510.1126/science.1081345 ↗
74. 10.1016/0026-2862(77)90137-610.1016/0026-2862(77)90137-6 ↗
75. 10.1016/S0955-0674(98)80044-610.1016/S0955-0674(98)80044-6 ↗
76. 10.1083/jcb.20040204610.1083/jcb.200402046 ↗
77. 10.1038/3509906610.1038/35099066 ↗
78. 10.1096/fasebj.5.8.185070510.1096/fasebj.5.8.1850705 ↗
79. 10.3109/03008207.2015.104792910.3109/03008207.2015.1047929 ↗
80. 10.1158/0008-5472.CAN-16-164610.1158/0008-5472.CAN-16-1646 ↗
81. 10.1038/bjc.2012.56910.1038/bjc.2012.569 ↗
82. 10.1093/jnci/88.18.128510.1093/jnci/88.18.1285 ↗
83. 10.1016/S0304-3835(98)00199-210.1016/S0304-3835(98)00199-2 ↗
84. 10.1158/1078-0432.CCR-07-473210.1158/1078-0432.CCR-07-4732 ↗
85. 10.1038/mt.2010.7910.1038/mt.2010.79 ↗
86. 10.1038/sj.bjc.660262610.1038/sj.bjc.6602626 ↗
87. 10.1158/0008-5472.CAN-03-147210.1158/0008-5472.CAN-03-1472 ↗
88. 10.1007/BF0004952010.1007/BF00049520 ↗
89. 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C ↗
90. 10.2353/ajpath.2006.06032410.2353/ajpath.2006.060324 ↗
91. 10.1016/0360-3016(95)02065-910.1016/0360-3016(95)02065-9 ↗
92. 10.1016/j.mvr.2007.09.00610.1016/j.mvr.2007.09.006 ↗
93. Sutherland R. M. · Cancer Res. · 1986 · 46 · 5320
94. 10.3389/fonc.2016.0006610.3389/fonc.2016.00066 ↗
95. 10.1126/science.116080910.1126/science.1160809 ↗
96. 10.1158/0008-5472.CAN-04-442610.1158/0008-5472.CAN-04-4426 ↗
97. 10.1158/0008-5472.CAN-03-269810.1158/0008-5472.CAN-03-2698 ↗
98. 10.1002/jcb.2118710.1002/jcb.21187 ↗
99. 10.1200/JCO.2012.46.365310.1200/JCO.2012.46.3653 ↗
100. 10.1016/j.mvr.2007.05.00310.1016/j.mvr.2007.05.003 ↗